RTTNews | Feb 25, 2021 04:25PM EST

16:20 Thursday, February 25, 2021 (RTTNews.com) - Biomarin Pharmaceutical Inc. (BMRN) announced a profit for its fourth quarter that rose from the same period last year.

The company's bottom line came in at $22.10 million, or $0.12 per share. This compares with $15.02 million, or $0.08 per share, in last year's fourth quarter.

Analysts had expected the company to earn -$0.19 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 0.5% to $452.12 million from $454.44 million last year.

Biomarin Pharmaceutical Inc. earnings at a glance:

-Earnings (Q4): $22.10 Mln. vs. $15.02 Mln. last year.-EPS (Q4): $0.12 vs. $0.08 last year.-Analysts Estimate: -$0.19-Revenue (Q4): $452.12 Mln vs. $454.44 Mln last year.

Read the original article on RTTNews ( https://www.rttnews.com/3173050/biomarin-pharmaceutical-inc-bottom-line-rises-in-q4.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved